Publications

5600 Results

New strategies to improve drug development in carcinoid tumors (Alliance A021202)

Authors
E Bergsland;S Geyer;M Mahoney;T Asmis;N Hall;S Karovic;M Knopp;P Kumthekar;A Nixon;E OReilly;L Schwartz;J Strosberg;J Meyerhardt;M Maitland
Journal / Conference
Neuroendocrine Tumor Research Foundation Research Symposium (November 2020), poster
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021202

Female sex is a potential independent predictor of adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

Authors
A Tarhini;S Lee;S Hodi;U Rao;G Cohen;O Hamid;L Hutchins;J Sosman;H Kluger;Z Eroglu;H Koon;D Lawrence;K Kendra;D Minor;C Lee;M Albertini;L Flaherty;T Petrella;H Streicher;V Sondak;J Kirkwood
Journal / Conference
Society for Immunotherapy of Cancer (SITC) Annual Meeting (November 10-15, 2020, virtual), poster
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Authors
A Brandao;P Paulo;S Maia;M Pinheiro;A Peixoto;M Cardoso;C Tangen;D Albanes;M Roobol;Profile Study Steering Cmte;PRACTICAL Consortium;M Teixeira
Journal / Conference
Cancers (Basel) Nov 4;12(11):3254. doi: 10.3390/cancers12113254
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33158149
PMC
PMC7694218
Study Number(s)
S0000, SWOG-9217

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Authors
T Andre;J Meyerhardt;T Iveson;A Sobrero;T Yoshino;I Souglakos;D Niedzwiecki;M Saunders;R Labianca;T Yamanaka;I Boukovinas;D Vernerey;J Meyers;A Harkin;V Torri;E Georgoulias;E Oki;J Taieb;AF Shields;Q Shi
Journal / Conference
Lancet Oncology Dec;21(12):1620-1629. doi: 10.1016/S1470-2045(20)30527-1.
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID33271092
PMC
PMC7786835
Study Number(s)
CTSU/C80702

Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

Authors
C Bull;J Bell;N Murphy;E Sanderson;G Smith;N Timpson;D Albanes;E Platz;C Tangen;A Wu;P Campbell;W Zheng;U Peters;E Vincent;M Gunter
Journal / Conference
BMC Medicine Dec 17;18(1):396
Year
2020
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33327948
PMC
PMC7745469
Study Number(s)
S0000

Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials

Authors
M Sedrak;C-L Sun;D Hershman;J Unger;J Liu;W Dale;D Dizon
Journal / Conference
JAMA Network Open Dec 1;3(12):e2031202
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID33369658
PMC
PMC7770556

ARID1A mutations induce an EGFR-like gene expression signature and confer intrinsic and acquired resistance to cetuximab treatment in first line metastatic CRC

Authors
R Johnson;X Qu;J Thomas;Y Kschonsak;L Huw;F-S Ou;E Sokol;N Ihuegbu;O Zill;O Kabbarah;A Daemen;R Bourgon;A Venook;F Innocenti;H-J Lenz;F de Sousa e Melo;C Bais
Journal / Conference
Cancer Research 2020;80(16 Suppl):Abstract LB-063. Proceedings of the Annual Meeting of the American Association for Cancer Research (AACR), 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA)
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer [Seminars Article; Review]

Authors
L Ballas;P Singh;SP Lerner
Journal / Conference
Urologic Oncology Nov 2;S1078-1439(20)30478-6.
Year
2020
Research Committee(s)
Genitourinary
PMID
PMID33153882
Study Number(s)
S1806

Key Design and Analysis Principles for Quality of Life and Patient Reported Outcomes in Clinical Trials

Authors
J Unger;R Vaidya;J Gore
Journal / Conference
Urologic Oncology May;37(5):324-330; Mar 21 [Epub ahead of print]
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID29572075
PMC
PMC6148417
Study Number(s)
S1802, S9916

From the other side:The patient perspective on cancer clinical trials [Review]

Authors
R Bangs;A Crispino
Journal / Conference
Urologic Oncology: Seminars and Original Investigations May;37(5):331-335; Feb 7 [Epub ahead of print]
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID29428573
Study Number(s)
S1314